Chinese Firm Halts Production of Controversial Alzheimer's Drug
A Chinese company that developed the country's first homegrown Alzheimer's disease therapy has suspended production of the drug, a local media report said, casting doubts on the treatment's future nearly five years after its approval.
Shanghai's Green Valley Pharmaceutical Co. informed employees of the production halt in an internal notice at the end of May, Yicai reported Monday, citing a person it didn't identify. The company failed to renew the drug's license and is currently waiting for regulatory review, the outlet reported, citing the source.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 minutes ago
- Yahoo
EVONET Launches Cross-Border Wallet Connectivity Service in Partnership with au PAY
— Enabling WeChat Pay Users to Pay at au PAY Merchants in Japan SINGAPORE, June 10, 2025 /PRNewswire/ -- EVONET Global Pte., Ltd. (Headquarters: Singapore, hereafter "EVONET") has launched a cross-border mobile wallet interoperability service in partnership with KDDI Corporation (Headquarters: Chiyoda-ku, Tokyo, hereafter "KDDI") and Tenpay Payment Technology Co., Ltd. (Headquarters: Shenzhen, China, hereafter "Tenpay"). In the first phase of this initiative, more than 1.4 billion WeChat users from China can make payments by WeChat Pay (Weixin Pay) at au PAY-affiliated stores across Japan by simply scanning the QR codes installed at the stores (MPM method: Merchant-Presented Mode). This enables inbound travelers from China to enjoy a seamless payment experience across Japan using their familiar WeChat app, without worrying about language or currency barriers. Japan welcomes tens of millions of inbound tourists annually, but differences in payment systems have been a significant inconvenience. With this collaboration, merchants do not need to install new systems or make complex configuration changes, enabling them to easily accept WeChat Pay users and capture inbound demand. "This marks the first time that KDDI is opening its au PAY merchant network to non-Japanese users. EVONET provides the technological platform that underpins this global collaboration, serving as a hub to address the complexities of international payment infrastructure." said James Zhao, chief executive officer of Evonet Global Pte., Ltd. Going forward, EVONET plans to expand its network by partnering with more mobile wallet providers across Asia. In addition to the MPM method, the company also plans to support the CPM method (Consumer-Presented Mode), where merchants scan the user's QR code, enabling more flexible payment options suited to various business types. EVONET aims to build an open network that allows multiple wallet operators to connect seamlessly across countries and regions, enabling users to pay easily using their regular mobile apps wherever they are. In the future, the company also envisions enabling Japanese users to make outbound payments at overseas merchants using their domestic mobile wallets, thereby enhancing global payment convenience. EVONET will continue to serve as a global bridge in mobile payments, delivering more seamless and valuable payment experiences for both users and merchants. About EVONET GLOBAL PTE., is a network service provider headquartered in Singapore, jointly planned and promoted by Shanghai CardInfoLink Data Service Co., LTD. The company provides merchant network access services for various mobile code payment wallets around the world. In addition to transaction processing between wallets and acquiring operators, EVONET also performs settlement and currency conversion to realize cross-border QR code payments. Future services will include international remittance and wallet top-up features. Media Contact:David Thoms | Marketing Manager+852 2663 3068 | media@ Learn more: View original content: SOURCE EVONET GLOBAL PTE LTD
Yahoo
13 minutes ago
- Yahoo
Huawei Founder Dismisses U.S. Export Control Concerns
U.S. chip restrictions won't have an impact on Huawei Technologies, its founder has said, dismissing concerns that it will be squeezed by export controls.
Yahoo
an hour ago
- Yahoo
Investing in StarHub (SGX:CC3) five years ago would have delivered you a 9.3% gain
For many, the main point of investing is to generate higher returns than the overall market. But every investor is virtually certain to have both over-performing and under-performing stocks. So we wouldn't blame long term StarHub Ltd (SGX:CC3) shareholders for doubting their decision to hold, with the stock down 14% over a half decade. So let's have a look and see if the longer term performance of the company has been in line with the underlying business' progress. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement. Looking back five years, both StarHub's share price and EPS declined; the latter at a rate of 3.0% per year. This change in EPS is remarkably close to the 3% average annual decrease in the share price. That suggests that the market sentiment around the company hasn't changed much over that time. So it's fair to say the share price has been responding to changes in EPS. You can see how EPS has changed over time in the image below (click on the chart to see the exact values). Dive deeper into StarHub's key metrics by checking this interactive graph of StarHub's earnings, revenue and cash flow. When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. As it happens, StarHub's TSR for the last 5 years was 9.3%, which exceeds the share price return mentioned earlier. This is largely a result of its dividend payments! While the broader market gained around 22% in the last year, StarHub shareholders lost 4.0% (even including dividends). Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Longer term investors wouldn't be so upset, since they would have made 1.8%, each year, over five years. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Even so, be aware that StarHub is showing 2 warning signs in our investment analysis , you should know about... But note: StarHub may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast). Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Singaporean exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
